Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity

Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity

US Patent 11638751 · Granted May 2, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lassa vaccine2024
Lassa vaccine2024
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with red2020
Methods and pharmaceutical compositions for the treatment of ebola virus disease2018